BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37558301)

  • 1. Investigation of Unexplained Cardiac Arrest: Phenotyping and Genetic Testing.
    Alsaeed AH; Alqarawi W
    Card Electrophysiol Clin; 2023 Sep; 15(3):307-318. PubMed ID: 37558301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest.
    Alqarawi W; Dewidar O; Tadros R; Roberts JD; Steinberg C; MacIntyre CJ; Laksman ZWM; Green MS; Nair G; Wells G; Krahn AD
    Heart Rhythm; 2021 Jul; 18(7):1178-1185. PubMed ID: 33781978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.
    Steinberg C; Padfield GJ; Champagne J; Sanatani S; Angaran P; Andrade JG; Roberts JD; Healey JS; Chauhan VS; Birnie DH; Janzen M; Gerull B; Klein GJ; Leather R; Simpson CS; Seifer C; Talajic M; Gardner M; Krahn AD
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
    Waldmann V; Bougouin W; Karam N; Dumas F; Sharifzadehgan A; Gandjbakhch E; Algalarrondo V; Narayanan K; Zhao A; Amet D; Jost D; Geri G; Lamhaut L; Beganton F; Ludes B; Bruneval P; Plu I; Hidden-Lucet F; Albuisson J; Lavergne T; Piot O; Alonso C; Leenhardt A; Lellouche N; Extramiana F; Cariou A; Jouven X; Marijon E;
    Eur Heart J; 2018 Jun; 39(21):1981-1987. PubMed ID: 29566157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome.
    Grace AA
    Lancet; 1999 Aug; 354(9177):445-6. PubMed ID: 10465166
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of genetic causes of cardiac arrest.
    Bennett MT; Sanatani S; Chakrabarti S; Deyell MW; Krahn AD
    Can J Cardiol; 2013 Jan; 29(1):100-10. PubMed ID: 23200097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia.
    Vittoria Matassini M; Krahn AD; Gardner M; Champagne J; Sanatani S; Birnie DH; Gollob MH; Chauhan V; Simpson CS; Hamilton RM; Talajic M; Ahmad K; Gerull B; Chakrabarti S; Healey JS
    Heart Rhythm; 2014 Feb; 11(2):274-81. PubMed ID: 24239842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brugada syndrome and sudden cardiac death in children.
    Priori SG; Napolitano C; Giordano U; Collisani G; Memmi M
    Lancet; 2000 Mar; 355(9206):808-9. PubMed ID: 10711933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initially unexplained cardiac arrest in children and adolescents: A national experience from the Canadian Pediatric Heart Rhythm Network.
    Cunningham T; Roston TM; Franciosi S; Liu MC; Atallah J; Escudero CA; Udupa S; Roberts JD; Dhillon S; Dallaire F; Fournier A; Fatah M; Hamilton R; Sanatani S
    Heart Rhythm; 2020 Jun; 17(6):975-981. PubMed ID: 32036023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic evaluation and arrhythmia mechanisms in survivors of unexplained cardiac arrest.
    Deif B; Roberts JD
    Pacing Clin Electrophysiol; 2019 Oct; 42(10):1320-1330. PubMed ID: 31411341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death and cardiac arrest without phenotype: the utility of genetic testing.
    Wijeyeratne YD; Behr ER
    Trends Cardiovasc Med; 2017 Apr; 27(3):207-213. PubMed ID: 27692676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience.
    Honarbakhsh S; Srinivasan N; Kirkby C; Firman E; Tobin L; Finlay M; Hunter RJ; Murphy C; Lowe MD; Schilling RJ; Lambiase PD
    Europace; 2017 Nov; 19(11):1874-1880. PubMed ID: 27738067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Steinberg C; Davies B; Mellor G; Tadros R; Laksman ZW; Roberts JD; Green M; Alqarawi W; Angaran P; Healey J; Sanatani S; Leather R; Seifer C; Fournier A; Duff H; Gardner M; McIntyre C; Hamilton R; Simpson CS; Krahn AD
    Eur Heart J; 2021 Jul; 42(29):2827-2838. PubMed ID: 34010395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonsynonymous polymorphism in semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillation.
    Nakano Y; Chayama K; Ochi H; Toshishige M; Hayashida Y; Miki D; Hayes CN; Suzuki H; Tokuyama T; Oda N; Suenari K; Uchimura-Makita Y; Kajihara K; Sairaku A; Motoda C; Fujiwara M; Watanabe Y; Yoshida Y; Ohkubo K; Watanabe I; Nogami A; Hasegawa K; Watanabe H; Endo N; Aiba T; Shimizu W; Ohno S; Horie M; Arihiro K; Tashiro S; Makita N; Kihara Y
    PLoS Genet; 2013 Apr; 9(4):e1003364. PubMed ID: 23593010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding a cause in sudden cardiac arrest survivors: Getting the testing right.
    Nalliah CJ; Raju H; Jagoda C; Semsarian C
    J Cardiovasc Electrophysiol; 2023 May; 34(5):1329-1331. PubMed ID: 36934399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of genetic testing in unexplained cardiac arrest.
    Grondin S; Davies B; Cadrin-Tourigny J; Steinberg C; Cheung CC; Jorda P; Healey JS; Green MS; Sanatani S; Alqarawi W; Angaran P; Arbour L; Antiperovitch P; Khan H; Leather R; Guerra PG; Rivard L; Simpson CS; Gardner M; MacIntyre C; Seifer C; Fournier A; Joza J; Gollob MH; Lettre G; Talajic M; Laksman ZW; Roberts JD; Krahn AD; Tadros R
    Eur Heart J; 2022 Aug; 43(32):3071-3081. PubMed ID: 35352813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic ventricular fibrillation: is it a case for genetic testing?
    van der Crabben SN; Wilde AAM
    Herzschrittmacherther Elektrophysiol; 2024 Mar; 35(1):19-24. PubMed ID: 38334831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quest for the identification of genetic variants in unexplained cardiac arrest and idiopathic ventricular fibrillation.
    Postema PG
    PLoS Genet; 2013 Apr; 9(4):e1003480. PubMed ID: 23593042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.